Posted on Leave a comment

Christen Brown from Santa Barbara: Transforming Hydration with OPHORA Water

Founded by Christen Brown from Santa Barbara, OPHORA is redefining clean, healthy hydration through its unique hyper-oxygenation technology. (Picture Credit: Christen Brown from Santa Barbara) In the picturesque coastal city of Santa Barbara, a silent revolution in the health and wellness industry is unfolding. Founded by Christen Brown from Santa Barbara, OPHORA Water, an industry […]

Posted on Leave a comment

1606 Corp ($CBDW) Gears Up for the Grand Launch of Its Revolutionary AI Chatbot – ChatCBDW

1606 Corp (CBDW) CEO Greg Lambrecht joined Steve Darling from Proactive to unveil some thrilling news: the impending launch of its cutting-edge AI chatbot, ChatCBDW. With ChatCBDW currently undergoing final testing phases, the countdown to its official launch is well underway. Lambrecht eagerly shared with Proactive the multifaceted capabilities that ChatCBDW is poised to bring to […]

Posted on Leave a comment

Five Solar Stocks Under A Dollar (SING, SIRC, SUNW, SAENF, WNDW)

Solar power remains at the forefront of renewable energy sources, as it allows us to tap into the sun’s infinite reserves to generate clean energy. Aside from the obvious environmental benefits, solar power stands out due to its capacity to spark economic growth and job creation, which is why governments across the globe have quickly […]

Posted on Leave a comment

La Rosa Holdings Is Acquiring Assets, Launching AI-Empowered Real Estate Technology, And Positioning For Breakout 2024 Growth ($LRHC)

La Rosa Holdings Corp (NASDAQ: LRHC) continues to do the right things at the right time, including leveraging its post-IPO strength to acquire net-income-producing assets and launching a revolutionary AI-empowered tool to support its roughly 2450 agents. And the better news for LRHC, its agents, and investors is that the pace of growth at LRHC […]

Posted on Leave a comment

Recent Research Indicates Acrylic Resin Market Poised to Thrive with a 6% CAGR

Acrylic Resin Market The global acrylic resin market size is anticipated to register a sustainable CAGR of over 6% during the forecast period from 2023 to 2030. The global acrylic resin market is expected to maintain a robust Compound Annual Growth Rate (CAGR) of over 6% from 2023 to 2030, according to forecasts. This growth […]

Posted on Leave a comment

T-Cell Lymphoma Pipeline Analysis Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Soligenix, Artiva, MediSix, ViGenCell, ImmuneOncia

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 90+ key pharma and biotech companies are working on 90+ pipeline drugs in the T-Cell Lymphoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and […]

Posted on Leave a comment

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Ascentage, Kronos Bio

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages […]

Posted on Leave a comment

HER2 Positive Gastric Cancer Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Pieris, Imugene, Mersana, Acepodia, Byondis

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the HER2 Positive Gastric Cancer therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical […]

Posted on Leave a comment

Psoriatic Arthritis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Mylan, Celltrion, Pfizer, Amgen, CinnaGen, Biogen, UCB

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Psoriatic Arthritis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and […]

Posted on Leave a comment

Recurrent Glioblastoma Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Ascletis, Genexine, PharmAbcine, VAXIMM, Chimerix

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 50+ key pharma and biotech companies are working on 50+ pipeline drugs in the Recurrent Glioblastoma therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and […]